DELDOSIN® – 8 mg Capsules

Description

Composition (Each Capsule Contains):

• Silodosin – 8 mg (Modified Release)

Form: Oral Capsule
Category: Urological | Alpha-1 Adrenergic Receptor Antagonist
Pack Size: 1×10 Capsules

---

Product Description:

DELDOSIN® 8 mg is a once-daily alpha-1 adrenergic blocker containing Silodosin, used to treat the lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) in adult men. It provides rapid and sustained relief from urinary difficulties such as hesitancy, weak stream, incomplete emptying, and frequent urination, improving both daytime and nighttime symptoms.

Its high selectivity for alpha-1A receptors in the prostate and bladder neck allows for targeted action with minimal effect on blood pressure.

---

Key Benefits:

• Relieves symptoms of enlarged prostate without reducing prostate size

• Improves urine flow and reduces nocturia

• Minimal impact on blood pressure, even in older adults

• Well-tolerated with low incidence of dizziness or orthostatic hypotension

• Once-daily dosing enhances patient compliance

---

How It Works:

Silodosin works by selectively blocking alpha-1A adrenergic receptors located in the smooth muscle of the prostate, urethra, and bladder neck. This leads to muscle relaxation, reducing bladder outlet resistance and improving urinary flow without affecting vascular smooth muscle, thus minimizing cardiovascular side effects.

---

How to Use:

• Take 1 capsule daily with food, preferably at the same time each day

• Swallow the capsule whole with water; do not crush or open

• Continue treatment as directed by your physician, even if symptoms improve early

---

Safety Advice:

• Do not stop the medication abruptly without medical advice

• May cause mild dizziness in some patients, especially at the start of therapy

• Report any unusual ejaculatory changes or persistent side effects to your doctor

• Not intended for use in women or children

---

Precautions:

• Use with caution in patients with severe renal or hepatic impairment

• Not recommended with strong CYP3A4 inhibitors (e.g., ketoconazole)

• Avoid driving or operating machinery until you know how the medicine affects you

• Store below 25°C, protected from light and moisture

• Keep out of reach of children